Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

III. THE ROLE OF THE RESEARCH ETHICS COMMITTEES IN THE REGULATION OF PHARMA-SPONSORED STUDIES.

Aguilar-Salinas CA, Pascual-Ramos V, Sierra-Madero JG, Loria-Acereto A, Zambrano-González E, Kaufer-Horwitz M, González-Duarte A.

Rev Invest Clin. 2019;71(5):297-305. doi: 10.24875/RIC.19002944.

PMID:
31599878
2.

Empowerment of patients with type 2 diabetes: current perspectives.

Gómez-Velasco DV, Almeda-Valdes P, Martagón AJ, Galán-Ramírez GA, Aguilar-Salinas CA.

Diabetes Metab Syndr Obes. 2019 Aug 6;12:1311-1321. doi: 10.2147/DMSO.S174910. eCollection 2019.

3.

II. THE RESEARCH ETHICS INVOLVING VULNERABLE GROUPS.

González-Duarte A, Zambrano-González E, Medina-Franco H, Alberú-Gómez J, Durand-Carbajal M, Hinojosa CA, Aguilar-Salinas CA, Kaufer-Horwitz M.

Rev Invest Clin. 2019;71(4):217-225. doi: 10.24875/RIC.19002812.

4.

Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.

Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, Mehta R, Elias-López D, Cruz-Bautista I, Roldán-Valadez E, Martagón AJ, Aguilar-Salinas CA.

Clin Nutr. 2019 Jul 30. pii: S0261-5614(19)30294-8. doi: 10.1016/j.clnu.2019.07.012. [Epub ahead of print]

PMID:
31400997
5.

Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index.

Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Martagón AJ, Mehta R, Arellano-Campos O, Gómez-Velasco DV, Almeda-Valdés P, Cruz-Bautista I, Melgarejo-Hernandez MA, Muñoz-Hernandez L, Guillén LE, Garduño-García JJ, Alvirde U, Ono-Yoshikawa Y, Choza-Romero R, Sauque-Reyna L, Garay-Sevilla ME, Malacara-Hernandez JM, Tusié-Luna MT, Gutierrez-Robledo LM, Gómez-Pérez FJ, Rojas R, Aguilar-Salinas CA.

J Clin Hypertens (Greenwich). 2019 Aug;21(8):1063-1070. doi: 10.1111/jch.13614. Epub 2019 Jul 18.

6.

I. THE ROLE OF RESEARCH ETHICS COMMITTEES IN OBSERVATIONAL STUDIES: EPIDEMIOLOGICAL REGISTRIES, CASE REPORTS, INTERVIEWS, AND RETROSPECTIVE STUDIES.

González-Duarte A, Kaufer-Horwitz M, Zambrano E, Durand-Carbajal M, Alberú-Gómez J, Galindo-Fraga A, Armenta-Espinosa A, Loria-Acereto A, Rull-Gabayet M, Medina-Franco H, Sierra-Salazar M, Hinojosa CA, Oseguera-Moguel J, Aguayo-González Á, Domínguez-Sánchez P, Hernández-Jiménez S, Aguilar-Salinas CA.

Rev Invest Clin. 2019;71(3):149-156. doi: 10.24875/RIC.18002580.

7.

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, Blackwell TW, Boerwinkle E, Brody JA, Centeno-Cruz F, Chen L, Chen S, Contreras-Cubas C, Córdova E, Correa A, Cortes M, DeFronzo RA, Dolan L, Drews KL, Elliott A, Floyd JS, Gabriel S, Garay-Sevilla ME, García-Ortiz H, Gross M, Han S, Heard-Costa NL, Jackson AU, Jørgensen ME, Kang HM, Kelsey M, Kim BJ, Koistinen HA, Kuusisto J, Leader JB, Linneberg A, Liu CT, Liu J, Lyssenko V, Manning AK, Marcketta A, Malacara-Hernandez JM, Martínez-Hernández A, Matsuo K, Mayer-Davis E, Mendoza-Caamal E, Mohlke KL, Morrison AC, Ndungu A, Ng MCY, O'Dushlaine C, Payne AJ, Pihoker C; Broad Genomics Platform, Post WS, Preuss M, Psaty BM, Vasan RS, Rayner NW, Reiner AP, Revilla-Monsalve C, Robertson NR, Santoro N, Schurmann C, So WY, Soberón X, Stringham HM, Strom TM, Tam CHT, Thameem F, Tomlinson B, Torres JM, Tracy RP, van Dam RM, Vujkovic M, Wang S, Welch RP, Witte DR, Wong TY, Atzmon G, Barzilai N, Blangero J, Bonnycastle LL, Bowden DW, Chambers JC, Chan E, Cheng CY, Cho YS, Collins FS, de Vries PS, Duggirala R, Glaser B, Gonzalez C, Gonzalez ME, Groop L, Kooner JS, Kwak SH, Laakso M, Lehman DM, Nilsson P, Spector TD, Tai ES, Tuomi T, Tuomilehto J, Wilson JG, Aguilar-Salinas CA, Bottinger E, Burke B, Carey DJ, Chan JCN, Dupuis J, Frossard P, Heckbert SR, Hwang MY, Kim YJ, Kirchner HL, Lee JY, Lee J, Loos RJF, Ma RCW, Morris AD, O'Donnell CJ, Palmer CNA, Pankow J, Park KS, Rasheed A, Saleheen D, Sim X, Small KS, Teo YY, Haiman C, Hanis CL, Henderson BE, Orozco L, Tusié-Luna T, Dewey FE, Baras A, Gieger C, Meitinger T, Strauch K, Lange L, Grarup N, Hansen T, Pedersen O, Zeitler P, Dabelea D, Abecasis G, Bell GI, Cox NJ, Seielstad M, Sladek R, Meigs JB, Rich SS, Rotter JI; DiscovEHR Collaboration; CHARGE; LuCamp; ProDiGY; GoT2D; ESP; SIGMA-T2D; T2D-GENES; AMP-T2D-GENES, Altshuler D, Burtt NP, Scott LJ, Morris AP, Florez JC, McCarthy MI, Boehnke M.

Nature. 2019 Jun;570(7759):71-76. doi: 10.1038/s41586-019-1231-2. Epub 2019 May 22.

8.

Rising rural body-mass index is the main driver of the global obesity epidemic in adults.

NCD Risk Factor Collaboration (NCD-RisC).

Nature. 2019 May;569(7755):260-264. doi: 10.1038/s41586-019-1171-x. Epub 2019 May 8.

9.

Disparities in prediabetes and type 2 diabetes prevalence between indigenous and nonindigenous populations from Southeastern Mexico: The Comitan Study.

Jimenez-Corona A, Nelson RG, Jimenez-Corona ME, Franks PW, Aguilar-Salinas CA, Graue-Hernandez EO, Hernandez-Jimenez S, Hernandez-Avila M.

J Clin Transl Endocrinol. 2019 Apr 20;16:100191. doi: 10.1016/j.jcte.2019.100191. eCollection 2019 Jun.

10.

Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort.

Arellano-Campos O, Gómez-Velasco DV, Bello-Chavolla OY, Cruz-Bautista I, Melgarejo-Hernandez MA, Muñoz-Hernandez L, Guillén LE, Garduño-Garcia JJ, Alvirde U, Ono-Yoshikawa Y, Choza-Romero R, Sauque-Reyna L, Garay-Sevilla ME, Malacara-Hernandez JM, Tusie-Luna MT, Gutierrez-Robledo LM, Gómez-Pérez FJ, Rojas R, Aguilar-Salinas CA.

BMC Endocr Disord. 2019 Apr 28;19(1):41. doi: 10.1186/s12902-019-0361-8.

11.

Recent advances in managing/understanding the metabolic syndrome.

Aguilar-Salinas CA, Viveros-Ruiz T.

F1000Res. 2019 Apr 3;8. pii: F1000 Faculty Rev-370. doi: 10.12688/f1000research.17122.1. eCollection 2019. Review.

12.

Long-term effectiveness of a type 2 diabetes comprehensive care program. The CAIPaDi model.

Hernández-Jiménez S, García-Ulloa AC, Bello-Chavolla OY, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D; Group of Study CAIPaDi.

Diabetes Res Clin Pract. 2019 May;151:128-137. doi: 10.1016/j.diabres.2019.04.009. Epub 2019 Apr 4.

PMID:
30954513
13.

Fibroblast Growth Factor 21 and Browning of White Adipose Tissue.

Cuevas-Ramos D, Mehta R, Aguilar-Salinas CA.

Front Physiol. 2019 Feb 5;10:37. doi: 10.3389/fphys.2019.00037. eCollection 2019. Review.

14.

Pathophysiological mechanisms linking type 2 diabetes and dementia: Review of evidence from clinical, translational and epidemiological research.

Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Ávila-Funes JA, Aguilar-Salinas CA.

Curr Diabetes Rev. 2019 Jan 15. doi: 10.2174/1573399815666190129155654. [Epub ahead of print]

PMID:
30648514
15.

A panel of 32 AIMs suitable for population stratification correction and global ancestry estimation in Mexican mestizos.

Huerta-Chagoya A, Moreno-Macías H, Fernández-López JC, Ordóñez-Sánchez ML, Rodríguez-Guillén R, Contreras A, Hidalgo-Miranda A, Alfaro-Ruíz LA, Salazar-Fernandez EP, Moreno-Estrada A, Aguilar-Salinas CA, Tusié-Luna T.

BMC Genet. 2019 Jan 8;20(1):5. doi: 10.1186/s12863-018-0707-7.

16.

[Development and validation of a screening score for prediabetes and undiagnosed diabetes.]

Rojas-Martínez R, Escamilla-Núñez C, Gómez-Velasco DV, Zárate-Rojas E, Aguilar-Salinas CA; Grupo colaborador de la cohorte para estimar la incidencia del síndrome metabólico; Grupo colaborador de la cohorte para estimar la incidencia del síndrome metabólico*.

Salud Publica Mex. 2018 Sep-Oct;60(5):500-509. doi: 10.21149/9057. Spanish.

PMID:
30550111
17.

Sucralose decreases insulin sensitivity in healthy subjects: a randomized controlled trial.

Romo-Romo A, Aguilar-Salinas CA, Brito-Córdova GX, Gómez-Díaz RA, Almeda-Valdes P.

Am J Clin Nutr. 2018 Sep 1;108(3):485-491. doi: 10.1093/ajcn/nqy152.

PMID:
30535090
18.

[Índices para la evaluación de la resistencia a la insulina en individuos mexicanos sin diabetes].

Almeda-Valdés P, Bello-Chavolla OY, Caballeros-Barragán CR, Gómez-Velasco DV, Viveros-Ruiz T, Vargas-Vázquez A, Aguilar-Salinas CA.

Gac Med Mex. 2018;154(Supp 2):S50-S55. doi: 10.24875/GMM.18004578. Spanish.

PMID:
30532124
19.

The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.

Almeda-Valdes P, Gómez Velasco DV, Arellano Campos O, Bello-Chavolla OY, Del Rocío Sevilla-González M, Viveros Ruiz T, Martagón Rosado AJ, Bautista CJ, Muñoz Hernandez L, Cruz-Bautista I, Moreno-Macias H, Huerta-Chagoya A, Rodríguez-Álvarez KG, Walford GA, Jacobs SBR, Guillen Pineda LE, Ordoñez-Sánchez ML, Roldan-Valadez E, Azpiroz J, Furuzawa-Carballeda J, Clark P, Herrera-Hernández MF, Zambrano E, Florez JC, Tusié Luna MT, Aguilar-Salinas CA.

Eur J Endocrinol. 2019 Feb 1;180(2):99-107. doi: 10.1530/EJE-18-0677.

PMID:
30475225
20.

Global Alliance for Chronic Disease researchers' statement on multimorbidity.

Hurst JR, Dickhaus J, Maulik PK, Miranda JJ, Pastakia SD, Soriano JB, Siddharthan T, Vedanthan R; GACD Multi-Morbidity Working Group.

Lancet Glob Health. 2018 Dec;6(12):e1270-e1271. doi: 10.1016/S2214-109X(18)30391-7. No abstract available. Erratum in: Lancet Glob Health. 2019 Feb;7(2):e190.

21.

Low Salivary Amylase Gene (AMY1) Copy Number Is Associated with Obesity and Gut Prevotella Abundance in Mexican Children and Adults.

León-Mimila P, Villamil-Ramírez H, López-Contreras BE, Morán-Ramos S, Macias-Kauffer LR, Acuña-Alonzo V, Del Río-Navarro BE, Salmerón J, Velazquez-Cruz R, Villarreal-Molina T, Aguilar-Salinas CA, Canizales-Quinteros S.

Nutrients. 2018 Nov 1;10(11). pii: E1607. doi: 10.3390/nu10111607.

22.

FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.

Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA.

Rev Invest Clin. 2018;70(5):224-236. doi: 10.24875/RIC.18002575. Review.

23.

DYSLIPIDEMIA IN MEXICO, A CALL FOR ACTION.

Rivas-Gomez B, Almeda-Valdés P, Tussié-Luna MT, Aguilar-Salinas CA.

Rev Invest Clin. 2018;70(5):211-216. doi: 10.24875/RIC.18002573. Review.

24.

LIPID DISORDERS: ADVANCES IN RESEARCH AND CHALLENGES IN CLINICAL PRACTICE.

Aguilar-Salinas CA, Tussié-Luna MT, Almeda-Valdés P.

Rev Invest Clin. 2018;70(5):209-210. doi: 10.24875/RIC.M18000001. No abstract available.

25.

Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.

Macias-Kauffer LR, Villamil-Ramírez H, León-Mimila P, Jacobo-Albavera L, Posadas-Romero C, Posadas-Sánchez R, López-Contreras BE, Morán-Ramos S, Romero-Hidalgo S, Acuña-Alonzo V, Del-Río-Navarro BE, Bortolini MC, Gallo C, Bedoya G, Rothhammer F, González-Jose R, Ruiz-Linares A, Stephens CR, Velazquez-Cruz R, Fernández Del Valle-Laisequilla C, Reyes-García JG, Barranco Garduño LM, Carrasco-Portugal MDC, Flores-Murrieta FJ, Vargas-Alarcón G, Aguilar-Salinas CA, Villarreal-Molina T, Canizales-Quinteros S.

Int J Cardiol. 2019 Mar 15;279:168-173. doi: 10.1016/j.ijcard.2018.09.107. Epub 2018 Oct 1.

PMID:
30305239
26.

The development of the Mexican Familial Hypercholesterolemia (FH) National Registry.

Mehta R, Martagon AJ, Galan Ramirez GA, Gonzalez Retana G, Martinez-Beltran M, Vargas Vazquez A, Vazquez-Cardenas A, Aguilar-Salinas CA.

Atherosclerosis. 2018 Oct;277:517-523. doi: 10.1016/j.atherosclerosis.2018.06.007. Review.

PMID:
30270093
27.

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, De Marco M, Stevens CAT, Akram A, Freiberger T, Hovingh GK, Kastelein JJP, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Al-Khnifsawi M, AlKindi FA, Alnouri F, Alonso R, Al-Rasadi K, Al-Sarraf A, Ashavaid TF, Binder CJ, Bogsrud MP, Bourbon M, Bruckert E, Chlebus K, Corral P, Descamps O, Durst R, Ezhov M, Fras Z, Genest J, Groselj U, Harada-Shiba M, Kayikcioglu M, Lalic K, Lam CSP, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi HM, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Postadzhiyan A, Reda A, Reiner Ž, Sadoh WE, Sahebkar A, Shehab A, Shek AB, Stoll M, Su TC, Subramaniam T, Susekov AV, Symeonides P, Tilney M, Tomlinson B, Truong TH, Tselepis AD, Tybjærg-Hansen A, Vázquez-Cárdenas A, Viigimaa M, Vohnout B, Widén E, Yamashita S, Banach M, Gaita D, Jiang L, Nilsson L, Santos LE, Schunkert H, Tokgözoğlu L, Car J, Catapano AL, Ray KK; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.

Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.

28.

Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes.

Muñoz-Hernandez L, Ortiz-Bautista RJ, Brito-Córdova G, Lozano-Arvizu F, Saucedo S, Pérez-Méndez O, Zentella-Dehesa A, Dauteuille C, Lhomme M, Lesnik P, Chapman MJ, Kontush A, Aguilar Salinas CA.

Atherosclerosis. 2018 Oct;277:72-79. doi: 10.1016/j.atherosclerosis.2018.08.027. Epub 2018 Aug 24.

PMID:
30176567
29.

Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.

Ibarra-González I, Cruz-Bautista I, Bello-Chavolla OY, Vela-Amieva M, Pallares-Méndez R, Ruiz de Santiago Y Nevarez D, Salas-Tapia MF, Rosas-Flota X, González-Acevedo M, Palacios-Peñaloza A, Morales-Esponda M, Aguilar-Salinas CA, Del Bosque-Plata L.

Acta Diabetol. 2018 Nov;55(11):1151-1161. doi: 10.1007/s00592-018-1213-0. Epub 2018 Sep 1.

PMID:
30173364
30.

[A front-of-pack labelling system for food and beverages for Mexico: a strategy of healthy decision-making.]

Kaufer-Horwitz M, Tolentino-Mayo L, Jáuregui A, Sánchez-Bazán K, Bourges H, Martínez S, Perichart O, Rojas-Russell M, Moreno L, Hunot C, Nava E, Ríos-Cortázar V, Palos-Lucio G, González L, González-de Cossio T, Pérez M, Borja Aburto VH, González A, Apolinar E, Pale LE, Colín E, Barriguete A, López O, López S, Aguilar-Salinas CA, Hernández-Ávila M, Martínez-Duncker D, de León F, Kershenobich D, Rivera J, Barquera S.

Salud Publica Mex. 2018 Jul-Ago;60(4):479-486. doi: 10.21149/9615. Spanish.

PMID:
30137950
31.

Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin.

Barquera S, Schillinger D, Aguilar-Salinas CA, Schenker M, Rodríguez LA, Hernández-Alcaraz C, Sepúlveda-Amor J; Mexico-California Diabetes collaborative group.

Global Health. 2018 Aug 22;14(1):84. doi: 10.1186/s12992-018-0390-5. Review.

32.

Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and Barriers.

Bermeo-Cabrera J, Almeda-Valdes P, Riofrios-Palacios J, Aguilar-Salinas CA, Mehta R.

J Diabetes Res. 2018 Jul 15;2018:3190849. doi: 10.1155/2018/3190849. eCollection 2018.

33.

Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values.

Sevilla-González MDR, Aguilar-Salinas CA, Muñóz-Hernández L, Almeda-Valdés P, Mehta R, Zubirán R, Bello-Chavolla OY, Gómez-Velasco DV, Vargas-Vázquez A, Viveros-Ruíz T, Martagón-Rosado AJ, Cruz-Bautista I.

Lipids Health Dis. 2018 Jul 18;17(1):156. doi: 10.1186/s12944-018-0803-8.

34.

Peripheral Lymphocytes, Obesity, and Metabolic Syndrome in Young Adults: An Immunometabolism Study.

Rodríguez CP, González MC, Aguilar-Salinas CA, Nájera-Medina O.

Metab Syndr Relat Disord. 2018 Sep;16(7):342-349. doi: 10.1089/met.2018.0005. Epub 2018 Jun 29.

PMID:
29957122
35.

Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.

Martagón AJ, Bello-Chavolla OY, Arellano-Campos O, Almeda-Valdés P, Walford GA, Cruz-Bautista I, Gómez-Velasco DV, Mehta R, Muñoz-Hernández L, Sevilla-González M, Viveros-Ruiz TL, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Florez JC, Tusié-Luna MT, Aguilar-Salinas CA; Slim Initiative in Genomic Medicine for the Americas (SIGMA) Type 2 Diabetes Consortium.

Diabetes Care. 2018 Aug;41(8):1726-1731. doi: 10.2337/dc18-0384. Epub 2018 May 29.

PMID:
29844095
36.

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis.

Lim LL, Lau ESH, Kong APS, Davies MJ, Levitt NS, Eliasson B, Aguilar-Salinas CA, Ning G, Seino Y, So WY, McGill M, Ogle GD, Orchard TJ, Clarke P, Holman RR, Gregg EW, Gagliardino JJ, Chan JCN.

Diabetes Care. 2018 Jun;41(6):1312-1320. doi: 10.2337/dc17-2010. Review.

37.

Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).

Danchin N, Almahmeed W, Al-Rasadi K, Azuri J, Berrah A, Cuneo CA, Karpov Y, Kaul U, Kayıkçıoğlu M, Mitchenko O, Ruiz AJ, Aguilar Salinas CA, Santos RD, Mercier F, Blom D; ICLPS Investigators.

Eur J Prev Cardiol. 2018 Jul;25(10):1087-1094. doi: 10.1177/2047487318777079. Epub 2018 May 17.

38.

[Prevalence of previously diagnosed diabetes mellitus in Mexico.]

Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T.

Salud Publica Mex. 2018 May-Jun;60(3):224-232. doi: 10.21149/8566. Spanish.

PMID:
29746739
40.

METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.

Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, Sánchez-Lázaro D, Meza-Oviedo D, Vargas-Vázquez A, Campos OA, Sevilla-González MDR, Martagón AJ, Hernández LM, Mehta R, Caballeros-Barragán CR, Aguilar-Salinas CA.

Eur J Endocrinol. 2018 May;178(5):533-544. doi: 10.1530/EJE-17-0883. Epub 2018 Mar 13.

PMID:
29535168
41.

Interaction Between Depression, Obesity, and Type 2 Diabetes: A Complex Picture.

Sevilla-González MDR, Quintana-Mendoza BM, Aguilar-Salinas CA.

Arch Med Res. 2017 Oct;48(7):582-591. doi: 10.1016/j.arcmed.2018.02.004. Epub 2018 Feb 22. Review.

PMID:
29478673
42.

Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits.

López-Contreras BE, Morán-Ramos S, Villarruel-Vázquez R, Macías-Kauffer L, Villamil-Ramírez H, León-Mimila P, Vega-Badillo J, Sánchez-Muñoz F, Llanos-Moreno LE, Canizalez-Román A, Del Río-Navarro B, Ibarra-González I, Vela-Amieva M, Villarreal-Molina T, Ochoa-Leyva A, Aguilar-Salinas CA, Canizales-Quinteros S.

Pediatr Obes. 2018 Jun;13(6):381-388. doi: 10.1111/ijpo.12262. Epub 2017 Dec 5.

PMID:
29388394
43.

Searching for the Causal Variants of the Association Between Hypertriglyceridemia and the Genome-Wide Association Studies-Derived Signals? Take a Look in the Native American Populations.

Aguilar-Salinas CA, Sevilla González MDR, Tusie-Luna MT.

Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e002010. doi: 10.1161/CIRCGENETICS.117.002010. No abstract available.

PMID:
29237696
44.

Frailty, diabetes, and the convergence of chronic disease in an age-related condition: a population-based nationwide cross-sectional analysis of the Mexican nutrition and health survey.

Castrejón-Pérez RC, Aguilar-Salinas CA, Gutiérrez-Robledo LM, Cesari M, Pérez-Zepeda MU.

Aging Clin Exp Res. 2018 Aug;30(8):935-941. doi: 10.1007/s40520-017-0852-2. Epub 2017 Nov 27.

PMID:
29181767
45.

Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus.

Jiménez IU, Díaz-Díaz E, Castro JS, Ramos JP, León MC, Alvarado Ríos JA, Auriostigue Bautista JC, Correa-Rotter R, Aguilar Salinas CA, Larrea F.

Arch Med Res. 2017 May;48(4):360-369. doi: 10.1016/j.arcmed.2017.07.001.

PMID:
29157674
46.
47.

A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes.

Mercader JM, Liao RG, Bell AD, Dymek Z, Estrada K, Tukiainen T, Huerta-Chagoya A, Moreno-Macías H, Jablonski KA, Hanson RL, Walford GA, Moran I, Chen L, Agarwala V, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Rodríguez-Torres M, Segura-Kato Y, García-Ortiz H, Centeno-Cruz F, Barajas-Olmos F, Caulkins L, Puppala S, Fontanillas P, Williams AL, Bonàs-Guarch S, Hartl C, Ripke S; Diabetes Prevention Program Research Group, Tooley K, Lane J, Zerrweck C, Martínez-Hernández A, Córdova EJ, Mendoza-Caamal E, Contreras-Cubas C, González-Villalpando ME, Cruz-Bautista I, Muñoz-Hernández L, Gómez-Velasco D, Alvirde U, Henderson BE, Wilkens LR, Le Marchand L, Arellano-Campos O, Riba L, Harden M; Broad Genomics Platform, Gabriel S; T2D-GENES Consortium, Abboud HE, Cortes ML, Revilla-Monsalve C, Islas-Andrade S, Soberon X, Curran JE, Jenkinson CP, DeFronzo RA, Lehman DM, Hanis CL, Bell GI, Boehnke M, Blangero J, Duggirala R, Saxena R, MacArthur D, Ferrer J, McCarroll SA, Torrents D, Knowler WC, Baier LJ, Burtt N, González-Villalpando C, Haiman CA, Aguilar-Salinas CA, Tusié-Luna T, Flannick J, Jacobs SBR, Orozco L, Altshuler D, Florez JC; SIGMA T2D Genetics Consortium.

Diabetes. 2017 Nov;66(11):2903-2914. doi: 10.2337/db17-0187. Epub 2017 Aug 24.

48.

An Amino Acid Signature Associated with Obesity Predicts 2-Year Risk of Hypertriglyceridemia in School-Age Children.

Moran-Ramos S, Ocampo-Medina E, Gutierrez-Aguilar R, Macías-Kauffer L, Villamil-Ramírez H, López-Contreras BE, León-Mimila P, Vega-Badillo J, Gutierrez-Vidal R, Villarruel-Vazquez R, Serrano-Carbajal E, Del-Río-Navarro BE, Huertas-Vázquez A, Villarreal-Molina T, Ibarra-Gonzalez I, Vela-Amieva M, Aguilar-Salinas CA, Canizales-Quinteros S.

Sci Rep. 2017 Jul 17;7(1):5607. doi: 10.1038/s41598-017-05765-4.

49.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

50.

Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.

Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, Carr SA, Wagner BK, Schenone M, Ng MCY, Chen BH; MEDIA Consortium; SIGMA T2D Consortium, Centeno-Cruz F, Zerrweck C, Orozco L, Altshuler DM, Schreiber SL, Florez JC, Jacobs SBR, Lander ES.

Cell. 2017 Jun 29;170(1):199-212.e20. doi: 10.1016/j.cell.2017.06.011.

Supplemental Content

Loading ...
Support Center